{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:21:46Z","timestamp":1792300906492,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Throughout the SARS-CoV2 pandemic, multiple reports show higher percentages of hospitalization, morbidity, and mortality among men than women, indicating that men are more affected by COVID-19. The pathophysiology of this difference is yet not established, but recent studies suggest that sex hormones may influence the viral infectivity process. Here, we review the current evidence of androgen sensitivity as a decisive factor for COVID-19 disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Relevant literature investigating the role of androgens in COVID-19 was assessed. Further, we describe several drugs suggested as beneficial for COVID-19 treatment related to androgen pathways. Lastly, we looked at androgen sensitivity as a predictor for COVID-19 progression and ongoing clinical trials on androgen suppression therapies as a line of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SARS-COV2 virus spike proteins utilize Transmembrane protease serine 2 (TMPRSS2) for host entry. Androgen receptors are transcription promoters for TMPRSS2 and can, therefore, facilitate SARS-COV2 entry. Variants in the androgen receptor gene correlate with androgen sensitivity and are implicated in diseases like androgenetic alopecia and prostate cancer, conditions that have been associated with worse COVID-19 outcomes and hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Androgen\u2019s TMPRSS2-mediated actions might explain both the low fatalities observed in prepubertal children and the differences between sexes regarding SARS-COV2 infection. Androgen sensitivity may be a critical factor in determining COVID-19 disease severity, and sensitivity tests can, therefore, help in predicting patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-020-02536-6","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T15:02:36Z","timestamp":1605106956000},"page":"3-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":172,"title":["Sex differences in COVID-19: the role of androgens in disease severity and progression"],"prefix":"10.1007","volume":"71","author":[{"given":"Mohamed S.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-5383","authenticated-orcid":false,"given":"Thiago C.","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi B.","family":"Schi\u00f6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"2536_CR1","doi-asserted-by":"publisher","unstructured":"R. Castagnoli, M. Votto, A. Licari, I. Brambilla, R. Bruno, S. Perlini et al. Severe Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatrics. American Medical Association, 882\u2013889 (2020). https:\/\/doi.org\/10.1001\/jamapediatrics.2020.1467","DOI":"10.1001\/jamapediatrics.2020.1467"},{"key":"2536_CR2","doi-asserted-by":"publisher","unstructured":"N. Sharifi, C.J. Ryan Editorial: Androgen hazards with COVID-19. Endocrine-Related Cancer. BioScientifica Ltd.; 2020. E1\u2013E3. https:\/\/doi.org\/10.1530\/ERC-20-0133","DOI":"10.1530\/ERC-20-0133"},{"key":"2536_CR3","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","volume":"198","author":"R Channappanavar","year":"2017","unstructured":"R. Channappanavar, C. Fett, M. Mack, P.P. Ten Eyck, D.K. Meyerholz, S. Perlman, Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J. Immunol. 198, 4046\u20134053 (2017). https:\/\/doi.org\/10.4049\/jimmunol.1601896","journal-title":"J. Immunol."},{"key":"2536_CR4","doi-asserted-by":"publisher","unstructured":"C.G. Wambier, A. Goren, S. Va\u00f1o-Galv\u00e1n, P.M. Ramos, A. Ossimetha, G. Nau et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. Wiley-Liss Inc.; 2020. https:\/\/doi.org\/10.1002\/ddr.21688","DOI":"10.1002\/ddr.21688"},{"key":"2536_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Kr\u00fcger, T. Herrler, S. Erichsen et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271\u2013280.e8 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"2536_CR6","doi-asserted-by":"publisher","unstructured":"A. Goren, S. Va\u00f1o-Galv\u00e1n, C.G. Wambier, J. McCoy, A. Gomez-Zubiaur, O.M. Moreno-Arrones et al. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain \u2013 A potential clue to the role of androgens in COVID-19 severity. J Cosmetic Dermatol. Blackwell Publishing Ltd; 2020. 1545\u20131547. https:\/\/doi.org\/10.1111\/jocd.13443","DOI":"10.1111\/jocd.13443"},{"key":"2536_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaad.2020.05.079","volume":"83","author":"CG Wambier","year":"2020","unstructured":"C.G. Wambier, S. Va\u00f1o-Galv\u00e1n, J. McCoy, A. Gomez-Zubiaur, S. Herrera, \u00c1. Hermosa-Gelbard et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The \u201cGabrin sign.\u201d. J. Am. Acad. Dermatol 83, 680\u2013682 (2020). https:\/\/doi.org\/10.1016\/j.jaad.2020.05.079","journal-title":"J. Am. Acad. Dermatol"},{"issue":"17","key":"2536_CR8","first-page":"4180","volume":"59","author":"B Lin","year":"1999","unstructured":"B. Lin, C. Ferguson, J.T. White, S. Wang, R. Vessella, L.D. True et al. Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS2. Cancer Res. 59(17), 4180\u20134184 (1999)","journal-title":"Cancer Res."},{"key":"2536_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/path.2330","volume":"215","author":"JM Lucas","year":"2008","unstructured":"J.M. Lucas, L. True, S. Hawley, M. Matsumura, C. Morrissey, R. Vessella et al. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J. Pathol. 215, 118\u2013125 (2008). https:\/\/doi.org\/10.1002\/path.2330","journal-title":"J. Pathol."},{"key":"2536_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mce.2009.12.022","volume":"317","author":"L Mikkonen","year":"2010","unstructured":"L. Mikkonen, P. Pihlajamaa, B. Sahu, F.P. Zhang, O.A. J\u00e4nne, Androgen receptor and androgen-dependent gene expression in lung. Mol. Cell Endocrinol. 317, 14\u201324 (2010). https:\/\/doi.org\/10.1016\/j.mce.2009.12.022","journal-title":"Mol. Cell Endocrinol."},{"key":"2536_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","volume":"31","author":"M Montopoli","year":"2020","unstructured":"M. Montopoli, S. Zumerle, R. Vettor, M. Rugge, M. Zorzi, C.V. Catapano et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann. Oncol. 31, 1040\u20131045 (2020). https:\/\/doi.org\/10.1016\/j.annonc.2020.04.479","journal-title":"Ann. Oncol."},{"key":"2536_CR12","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1073\/pnas.94.7.3320","volume":"94","author":"E Giovannucci","year":"1997","unstructured":"E. Giovannucci, M.J. Stampfer, K. Krithivas, M. Brown, A. Brufsky, J. Talcott et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl Acad. Sci. USA 94, 3320\u20133323 (1997). https:\/\/doi.org\/10.1073\/pnas.94.7.3320","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2536_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/120347549800300103","volume":"3","author":"ME Sawaya","year":"1998","unstructured":"M.E. Sawaya, A.R. Shalita, Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J. Cutan. Med. Surg. 3, 9\u201315 (1998). https:\/\/doi.org\/10.1177\/120347549800300103","journal-title":"J. Cutan. Med. Surg."},{"key":"2536_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/431425","volume":"77","author":"AM Hillmer","year":"2005","unstructured":"A.M. Hillmer, S. Hanneken, S. Ritzmann, T. Becker, J. Freudenberg, F.F. Brockschmidt et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am. J. Hum. Genet 77, 140\u2013148 (2005). https:\/\/doi.org\/10.1086\/431425","journal-title":"Am. J. Hum. Genet"},{"key":"2536_CR15","doi-asserted-by":"publisher","unstructured":"M. Schroeder, B. Tuku, D. Jarczak, A. Nierhaus, T. Bai, H. Jacobsen et al. The majority of male patients with COVID-19 present low testosterone levels on admission to Intensive Care in Hamburg, Germany: a retrospective cohort study. medRxiv. 2020; 2020.05.07.20073817. https:\/\/doi.org\/10.1101\/2020.05.07.20073817","DOI":"10.1101\/2020.05.07.20073817"},{"key":"2536_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/andr.12821","volume":"00","author":"G Rastrelli","year":"2020","unstructured":"G. Rastrelli, V. Di Stasi, F. Inglese, M. Beccaria, M. Garuti, D. Di Costanzo et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology 00, 1\u201311 (2020). https:\/\/doi.org\/10.1111\/andr.12821","journal-title":"Andrology"},{"key":"2536_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1756287215612961","volume":"8","author":"JA McBride","year":"2016","unstructured":"J.A. McBride, C.C. Carson, R.M. Coward, Testosterone deficiency in the aging male. Ther. Adv. Urol. 8, 47\u201360 (2016). https:\/\/doi.org\/10.1177\/1756287215612961","journal-title":"Ther. Adv. Urol."},{"key":"2536_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/jsm.12546","volume":"11","author":"A Morgentaler","year":"2014","unstructured":"A. Morgentaler, M. Khera, M. Maggi, M. Zitzmann, Commentary: who Is a Candidate for Testosterone Therapy? A Synthesis of International Expert Opinions. J. Sex. Med. 11, 1636\u20131645 (2014). https:\/\/doi.org\/10.1111\/jsm.12546","journal-title":"J. Sex. Med."},{"key":"2536_CR19","doi-asserted-by":"publisher","unstructured":"J. Bobjer, M. Katrinaki, C. Tsatsanis, Y. Lundberg Giwercman, A. Giwercman. Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. PLoS ONE. 2013;8. https:\/\/doi.org\/10.1371\/journal.pone.0061466","DOI":"10.1371\/journal.pone.0061466"},{"issue":"11 Suppl Procee","key":"2536_CR20","first-page":"116","volume":"28","author":"M Maggio","year":"2005","unstructured":"M. Maggio, S. Basaria, G.P. Ceda, A. Ble, S.M. Ling, S. Bandinelli et al. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Investig. 28(11 Suppl Proceedings), 116\u2013119 (2005).","journal-title":"J Endocrinol Investig."},{"key":"2536_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1745-7262.2007.00250.x","volume":"9","author":"R Singh","year":"2007","unstructured":"R. Singh, L. Singh, K. Thangaraj, Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J. Androl. 9, 147\u2013179 (2007). https:\/\/doi.org\/10.1111\/j.1745-7262.2007.00250.x","journal-title":"Asian J. Androl."},{"key":"2536_CR22","doi-asserted-by":"publisher","unstructured":"M Zitzmann. The Role of the CAG Repeat Androgen Receptor Polymorphism in Andrology. Advances in the Management of Testosterone Deficiency (KARGER, Basel, 2008), 52\u201361. https:\/\/doi.org\/10.1159\/000175843","DOI":"10.1159\/000175843"},{"key":"2536_CR23","doi-asserted-by":"publisher","unstructured":"J. McCoy, C.G. Wambier, S. Vano-Galvan, J. Shapiro, R. Sinclair, P.M. Ramos et al. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmetic Dermatol. Blackwell Publishing Ltd, 1542\u20131543 (2020). https:\/\/doi.org\/10.1111\/jocd.13455","DOI":"10.1111\/jocd.13455"},{"key":"2536_CR24","doi-asserted-by":"publisher","unstructured":"R. Wu, L. Wang, H.C.D. Kuo, A. Shannar, R. Peter, P.J. Chou et al. An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports. Springer; 2020. 56\u201370. https:\/\/doi.org\/10.1007\/s40495-020-00216-7","DOI":"10.1007\/s40495-020-00216-7"},{"key":"2536_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.18433\/jpps31002","volume":"23","author":"MII Rabby","year":"2020","unstructured":"M.I.I. Rabby, Current drugs with potential for treatment of covid-19: a literature review. J. Pharm. Pharm. Sci. 23, 58\u201364 (2020). https:\/\/doi.org\/10.18433\/jpps31002","journal-title":"J. Pharm. Pharm. Sci."},{"key":"2536_CR26","doi-asserted-by":"publisher","unstructured":"P. Horby, W.S. Lim, J. Emberson, M. Mafham, J. Bell, L. Linsell et al. Dexamethasone for COVID-19-Preliminary Report Effect of Dexamethasone in Hospitalized Patients with COVID-19-Preliminary Report RECOVERY Collaborative Group*. medRxiv. 2020; 2020.06.22.20137273. https:\/\/doi.org\/10.1101\/2020.06.22.20137273","DOI":"10.1101\/2020.06.22.20137273"},{"key":"2536_CR27","doi-asserted-by":"publisher","unstructured":"M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research. Springer Nature; 2020. 269\u2013271. https:\/\/doi.org\/10.1038\/s41422-020-0282-0","DOI":"10.1038\/s41422-020-0282-0"},{"key":"2536_CR28","doi-asserted-by":"publisher","first-page":"105945","DOI":"10.1016\/j.ijantimicag.2020.105945","volume":"55","author":"Z Sahraei","year":"2020","unstructured":"Z. Sahraei, M. Shabani, S. Shokouhi, A. Saffaei, Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Int J. Antimicrob. Agents 55, 105945 (2020). https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105945","journal-title":"Int J. Antimicrob. Agents"},{"key":"2536_CR29","unstructured":"U.S. Food and Drug Administration. Coronavirus (COVID-19) update: FDA revokes emergency use authorization for chloroquine andhydroxychloroquine [news release]. 15 June 2020. Accessed at www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-revokesemergency-use-authorization-chloroquine-and on 16 July 2020"},{"key":"2536_CR30","first-page":"39","volume":"136","author":"WG Nicola","year":"1997","unstructured":"W.G. Nicola, M.I. Khayria, M.M.H. Osfor, Plasma testosterone level and the male genital system after chloroquine therapy. Boll. Chim. Farm. 136, 39\u201343 (1997)","journal-title":"Boll. Chim. Farm."},{"key":"2536_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3892\/ijmm.2020.4476","volume":"45","author":"L Gu","year":"2020","unstructured":"L. Gu, D. Lian, Y. Zheng, W. Zhou, J. Gu, X. Liu, Echinacoside\u2011induced nitric oxide production in endothelial cells: Roles of androgen receptor and the PI3K\u2011Akt pathway. Int J. Mol. Med. 45, 1195\u20131202 (2020). https:\/\/doi.org\/10.3892\/ijmm.2020.4476","journal-title":"Int J. Mol. Med."},{"key":"2536_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/sj.onc.1209984","volume":"26","author":"MV Cronauer","year":"2007","unstructured":"M.V. Cronauer, Y. Ince, R. Engers, L. Rinnab, W. Weidemann, C.V. Suschek et al. Nitric oxide-mediated inhibition of androgen receptor activity: Possible implications for prostate cancer progression. Oncogene. 26, 1875\u20131884 (2007). https:\/\/doi.org\/10.1038\/sj.onc.1209984","journal-title":"Oncogene."},{"key":"2536_CR33","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1128\/jvi.79.3.1966-1969.2005","volume":"79","author":"S \u00c5kerstr\u00f6m","year":"2005","unstructured":"S. \u00c5kerstr\u00f6m, M. Mousavi-Jazi, J. Klingstr\u00f6m, M. Leijon, \u00c5. Lundkvist, A. Mirazimi, Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus. J. Virol. 79, 1966\u20131969 (2005). https:\/\/doi.org\/10.1128\/jvi.79.3.1966-1969.2005","journal-title":"J. Virol."},{"key":"2536_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2009.09.007","volume":"395","author":"S \u00c5kerstr\u00f6m","year":"2009","unstructured":"S. \u00c5kerstr\u00f6m, V. Gunalan, C.T. Keng, Y.J. Tan, A. Mirazimi, Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected. Virology. 395, 1\u20139 (2009). https:\/\/doi.org\/10.1016\/j.virol.2009.09.007","journal-title":"Virology."},{"key":"2536_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.acthis.2018.12.004","volume":"121","author":"L Annie","year":"2019","unstructured":"L. Annie, G. Gurusubramanian, V. Kumar Roy, Dexamethasone mediated downregulation of PGC-1\u03b1 and visfatin regulates testosterone synthesis and antioxidant system in mouse testis. Acta Histochem. 121, 182\u2013188 (2019). https:\/\/doi.org\/10.1016\/j.acthis.2018.12.004","journal-title":"Acta Histochem."},{"key":"2536_CR36","first-page":"179","volume-title":"Immunosuppressants and male reproduction. Advances in Experimental Medicine and Biology","author":"EZ Drobnis","year":"2017","unstructured":"E.Z. Drobnis, A.K. Nangia. Immunosuppressants and male reproduction. Advances in Experimental Medicine and Biology. (Springer New York LLC, New York, NY), 2017) 179\u2013210. 10.1007\/978-3-319-69535-8_12"},{"key":"2536_CR37","doi-asserted-by":"publisher","unstructured":"Z. Ghazizadeh, H. Majd, M. Richter, R. Samuel, S.M. Zekavat, H. Asgharian et al. Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. bioRxiv Prepr Serv Biol. 2020; 2020.05.12.091082. https:\/\/doi.org\/10.1101\/2020.05.12.091082","DOI":"10.1101\/2020.05.12.091082"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02536-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T09:24:28Z","timestamp":1620379468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02536-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2536"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02536-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}